Doctor profile · Federal record
Dr. Alka Rebentish, MD
Infectious Disease Physician (CMS: Infectious Disease) · Las Vegas, NV
- NPI 1427012806
- Accepts Medicare
- 45 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6088 S Durango Dr Ste 100
Las Vegas, NV 891131780
(702) 380-4242
fax (702) 380-4141 - Mailing address
-
1450 W Horizon Ridge Pkwy, B304 #668
Henderson, NV 89012
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- April 24, 2025
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Nevada #8061
- Medicaid
- NV #2002678
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427012806. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
636
Distinct HCPCS
7
Medicare allowed
$80,194
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 313 | 181 | $118 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 109 | 105 | $172 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 102 | 78 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 56 | 47 | $87 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 25 | 25 | $164 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 17 | 15 | $67 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 14 | 14 | $112 |
In context: peer comparison
Among 21 peers in Las Vegas Infectious Disease Physician, average services per provider: 3,511. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$2,698
Transactions
112
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 40 | $881.78 | |
| Gilead Sciences, INC. | 15 | $295.98 | |
| Astellas Pharma US INC | 7 | $276.08 | |
| Abbvie INC. | 12 | $244.59 | |
| Merck Sharp & Dohme LLC | 8 | $191.57 | |
| Melinta Therapeutics, LLC | 4 | $187.60 | |
| Ferring Pharmaceuticals INC. | 6 | $162.42 | |
| Shionogi INC | 10 | $143.34 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $121.15 | |
| Insmed, INC. | 4 | $92.87 | |
| Paratek Pharmaceuticals, INC. | 3 | $56.21 | |
| Aimmune Therapeutics, INC. | 1 | $25.79 | |
| Napo Pharmaceuticals INC | 1 | $18.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
677
Patients
121
Total drug cost
$1,433,605
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 260 | 34 | $1,060,361 |
| Dovato (Dolutegravir Sodium/Lamivudine) | Brand | 54 | 0 | $161,489 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 49 | 18 | $3,229 |
| Daptomycin | Generic | 41 | 0 | $58,812 |
| Isoniazid | Generic | 36 | 0 | $272 |
| Cefepime Hcl | Generic | 32 | 0 | $10,680 |
| Cephalexin | Generic | 31 | 11 | $430 |
| Triumeq (Abacavir/Dolutegravir/Lamivudi) | Brand | 25 | 0 | $97,474 |
| Ertapenem (Ertapenem Sodium) | Brand | 24 | 16 | $12,881 |
| Fluconazole | Generic | 22 | 11 | $811 |
Hospital affiliations
Frequently asked questions
What is Dr. Alka Rebentish's medical specialty?
Dr. Alka Rebentish practices Infectious Disease Physician in Las Vegas, NV.
Where does Dr. Alka Rebentish practice?
Dr. Alka Rebentish practices at 6088 S Durango Dr Ste 100, Las Vegas, NV 891131780. Office phone: 7023804242.
What is Dr. Alka Rebentish's NPI?
Dr. Alka Rebentish's National Provider Identifier (NPI) is 1427012806, issued by NPPES.
Does Dr. Alka Rebentish accept Medicare assignment?
Yes. Dr. Alka Rebentish accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alka Rebentish commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Initial hospital care with moderate level of medical decision making (HCPCS 99223); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.